2016 American Transplant Congress
Factors Predicting Tacrolimus Trough Variability After Lung Transplantation.
The Johns Hopkins Hospital, Baltimore, MD.
Background: Recent data suggests that variability in tacrolimus trough concentrations is associated with acute and chronic rejection. The purpose of this study was to identify…2016 American Transplant Congress
Effect of Early Tacrolimus Trough Variability on Graft Outcomes in Lung Transplantation.
The Johns Hopkins Hospital, Baltimore, MD.
Background: Recent data suggests that variability in tacrolimus trough levels after lung transplant may be associated with poor long term graft outcomes. The purpose of…2016 American Transplant Congress
Achieving Timely Therapeutic Mycophenolic Acid Levels in Pediatric Lung Transplant Patients.
Texas Children's Hospital, Houston, TX.
The purpose of this study was to determine the appropriate initial dose of mycophenolate mofetil (MMF) in pediatric cystic fibrosis (CF) and non-CF lung transplant…2016 American Transplant Congress
Characteristics and Outcome of Patients Placed on Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation.
University of Texas Southwestern Medical Center, Dallas, TX.
BackgroundExtracorporeal membrane oxygenation (ECMO) is increasingly utilized as bridge to lung transplantation (LT), with studies reporting one-year survival of 50-90%. Lower than expected survival has…2016 American Transplant Congress
Outcomes in Lung Transplant Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) in the Perioperative Period.
Cardiovascular Surger, Hospital of the University of Pennsylvania, Philadelphia, PA.
Objective As ECMO therapy is increasingly used to bridge high-risk patients with end-stage respiratory failure to lung transplantation, outcomes of this strategy employed in the…2016 American Transplant Congress
Hospitalizations, Survival, and Complications: 1-Year Outcomes for Elderly Lung Transplant Recipients.
Houston Methodist Hospital, Houston, TX.
Purpose: In 2014, The International Society for Heart and Lung Transplantation published consensus guidelines listing age greater than 65 years as a relative contraindication to…2016 American Transplant Congress
Comparison of Clinical Outcomes in Lung Transplant Patients with and without Preoperative Pulmonary Hypertension.
St. Joseph's Hospital and Medical Center, Phoenix.
Purpose: End-stage lung disease patients (pts) who undergo lung transplantation (LTx) with an elevated mean pulmonary artery pressure (mPAP) are known to have adverse outcomes.…2016 American Transplant Congress
The Effect of Body Mass Index on Lung Transplant Outcomes.
Background: Lung transplant (LTx) has the potential to effectively extend the life expectancy for patients with end-stage lung disease. Both high and low body mass…2016 American Transplant Congress
Pre-Transplant Prostate Cancer in Lung Transplant Recipients and Impact on Post-Transplant Morbidity and Mortality.
Respiratory Institute, Cleveland Clinic, Cleveland, OH.
PurposeAssess the impact of pre-transplant prostate cancer on mortality after lung transplant and the incidence of recurrence of prostate cancer after transplant.MethodsThe electronic medical records…2016 American Transplant Congress
The Role of Palliative Care in the Thoracic Transplant Multidisciplinary Care Team: Barriers and Benefits.
1Loyola University Medical Center, Maywood, IL; 2Terre Haute Regional Hospital, Terre Haute, IN.
PURPOSE: Patients under consideration for or who have undergone lung and heart transplantation experience many symptoms, including dyspnea, anxiety, pain and caregiver burden. Integration of…
American Transplant Congress abstracts